The chemopreventive and clinically used agent curcumin sensitizes HPV^- but not HPV⁺ HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model

References

• Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005; 5:127 - 35; http://dx.doi.org/10.1038/nrc1549; PMID: 15685196
   PubMed Web of Science ®Google Scholar
• Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11:9 - 22; http://dx.doi.org/10.1038/nrc2982; PMID: 21160525
   PubMed Web of Science ®Google Scholar
• Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11:781 - 9; http://dx.doi.org/10.1016/S1470-2045(10)70017-6; PMID: 20451455
   PubMed Web of Science ®Google Scholar
• Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31:744 - 54; http://dx.doi.org/10.1053/j.seminoncol.2004.09.011; PMID: 15599852
   PubMed Web of Science ®Google Scholar
• Hobbs CGL, Sterne JAC, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006; 31:259 - 66; http://dx.doi.org/10.1111/j.1749-4486.2006.01246.x; PMID: 16911640
   PubMed Web of Science ®Google Scholar
• Ragin CCR, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121:1813 - 20; http://dx.doi.org/10.1002/ijc.22851; PMID: 17546592
   PubMed Web of Science ®Google Scholar
• Vu HL, Sikora AG, Fu S, Kao J. HPV-induced oropharyngeal cancer, immune response and response to therapy. Cancer Lett 2010; 288:149 - 55; http://dx.doi.org/10.1016/j.canlet.2009.06.026; PMID: 19628331
   PubMed Web of Science ®Google Scholar
• Gupta AK, Lee JH, Wilke WW, Quon H, Smith G, Maity A, et al. Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT. Int J Radiat Oncol Biol Phys 2009; 74:928 - 33; http://dx.doi.org/10.1016/j.ijrobp.2009.03.004; PMID: 19480971
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24 - 35; http://dx.doi.org/10.1056/NEJMoa0912217; PMID: 20530316
   PubMed Web of Science ®Google Scholar
• Lindel K, Beer KT, Laissue J, Greiner RH, Aebersold DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 2001; 92:805 - 13; http://dx.doi.org/10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; PMID: 11550151
   PubMed Web of Science ®Google Scholar
• Tobias JS, Monson K, Gupta N, Macdougall H, Glaholm J, Hutchison I, et al, UK Head and Neck Cancer Trialists’ Group. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial. Lancet Oncol 2010; 11:66 - 74; http://dx.doi.org/10.1016/S1470-2045(09)70306-7; PMID: 19875337
   PubMed Web of Science ®Google Scholar
• Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al, Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350:1937 - 44; http://dx.doi.org/10.1056/NEJMoa032646; PMID: 15128893
   PubMed Web of Science ®Google Scholar
• Adelstein DJ, Li Y, Adams GL, Wagner H Jr., Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003; 21:92 - 8; http://dx.doi.org/10.1200/JCO.2003.01.008; PMID: 12506176
   PubMed Web of Science ®Google Scholar
• Specenier PM, Vermorken JB. Current concepts for the management of head and neck cancer: chemotherapy. Oral Oncol 2009; 45:409 - 15; http://dx.doi.org/10.1016/j.oraloncology.2008.05.014; PMID: 18715812
   PubMed Web of Science ®Google Scholar
• Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349:2091 - 8; http://dx.doi.org/10.1056/NEJMoa031317; PMID: 14645636
   PubMed Web of Science ®Google Scholar
• Marur S, Forastiere AA. Update on role of chemotherapy in head and neck squamous cell cancer. Indian J Surg Oncol 2009; 1:85 - 95; http://dx.doi.org/10.1007/s13193-010-0021-y
   Google Scholar
• Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65:1631 - 52; http://dx.doi.org/10.1007/s00018-008-7452-4; PMID: 18324353
   PubMed Web of Science ®Google Scholar
• Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer 2005; 41:1955 - 68; http://dx.doi.org/10.1016/j.ejca.2005.05.009; PMID: 16081279
   PubMed Web of Science ®Google Scholar
• Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett 2008; 267:133 - 64; http://dx.doi.org/10.1016/j.canlet.2008.03.025; PMID: 18462866
   PubMed Web of Science ®Google Scholar
• Steward WP, Gescher AJ. Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research. Mol Nutr Food Res 2008; 52:1005 - 9; http://dx.doi.org/10.1002/mnfr.200700148; PMID: 18186103
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004; 10:6847 - 54; http://dx.doi.org/10.1158/1078-0432.CCR-04-0744; PMID: 15501961
   PubMed Web of Science ®Google Scholar
• Lao CD, Ruffin MT 4th, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006; 6:10; http://dx.doi.org/10.1186/1472-6882-6-10; PMID: 16545122
   PubMedGoogle Scholar
• Javvadi P, Segan AT, Tuttle SW, Koumenis C. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 2008; 73:1491 - 501; http://dx.doi.org/10.1124/mol.107.043554; PMID: 18252805
   PubMed Web of Science ®Google Scholar
• Javvadi P, Hertan L, Kosoff R, Datta T, Kolev J, Mick R, et al. Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells. Cancer Res 2010; 70:1941 - 50; http://dx.doi.org/10.1158/0008-5472.CAN-09-3025; PMID: 20160040
   PubMed Web of Science ®Google Scholar
• Khafif A, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE. Curcumin: a new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 2005; 132:317 - 21; http://dx.doi.org/10.1016/j.otohns.2004.09.006; PMID: 15692547
   PubMed Web of Science ®Google Scholar
• Khafif A, Lev-Ari S, Vexler A, Barnea I, Starr A, Karaush V, et al. Curcumin: a potential radio-enhancer in head and neck cancer. Laryngoscope 2009; 119:2019 - 26; http://dx.doi.org/10.1002/lary.20582; PMID: 19655336
   PubMed Web of Science ®Google Scholar
• Shehzad A, Lee YS. Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review. Drugs Future 2010; 35:113
   Web of Science ®Google Scholar
• Ravindram J, Prasad S, Aggarwal BB. Curcmin and cancer cells: How many ways can curry kill tumor cells selectively?. AAPS J 2009; 3:495 - 510; http://dx.doi.org/10.1208/s12248-009-9128-x
   Web of Science ®Google Scholar
• Holmgren A, Lu J. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun 2010; 396:120 - 4; http://dx.doi.org/10.1016/j.bbrc.2010.03.083; PMID: 20494123
   PubMed Web of Science ®Google Scholar
• Powis G, Kirkpatrick DL. Thioredoxin signaling as a target for cancer therapy. Curr Opin Pharmacol 2007; 7:392 - 7; http://dx.doi.org/10.1016/j.coph.2007.04.003; PMID: 17611157
   PubMed Web of Science ®Google Scholar
• Nguyen P, Awwad RT, Smart DDK, Spitz DR, Gius D. Thioredoxin reductase as a novel molecular target for cancer therapy. Cancer Lett 2006; 236:164 - 74; http://dx.doi.org/10.1016/j.canlet.2005.04.028; PMID: 15955621
   PubMed Web of Science ®Google Scholar
• Biaglow JE, Miller RA. The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Cancer Biol Ther 2005; 4:6 - 13; http://dx.doi.org/10.4161/cbt.4.1.1434; PMID: 15684606
   PubMed Web of Science ®Google Scholar
• Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res 2003; 23:3B 2425 - 33; PMID: 12894524
   PubMed Web of Science ®Google Scholar
• Yoo MH, Carlson BA. Tsuji, Irons R, Gladyshev VN, Hatfield DL. Alterartion of Thioredoxin Reductase 1 levels in elucidation cancer etiology. Methods Enzymol 2010; 474:255 - 75; http://dx.doi.org/10.1016/S0076-6879(10)74015-5; PMID: 20609915
   PubMed Web of Science ®Google Scholar
• Zhu X, Huang C, Peng B. Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue. Oral Oncol 2011; 47:609 - 14; http://dx.doi.org/10.1016/j.oraloncology.2011.05.006; PMID: 21652258
   PubMed Web of Science ®Google Scholar
• Lincoln DT, Al-Yatama F, Mohammed FMA, Al-Banaw A, Al-Bader M, Burge M, et al. Thioredoxin and thioredoxin reductase expression in thyroid cancer depends on tumor aggressiveness. Anticancer Res 2010; 30:67 - 76
   Google Scholar
• Sacks PG. Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev 1996; 15:27 - 51; http://dx.doi.org/10.1007/BF00049486; PMID: 8842478
   PubMed Web of Science ®Google Scholar
• Biaglow JE, Donahue J, Tuttle S, Held K, Chrestensen C, Mieyal J. A method for measuring disulfide reduction by cultured mammalian cells: relative contributions of glutathione-dependent and glutathione-independent mechanisms. Anal Biochem 2000; 281:77 - 86; http://dx.doi.org/10.1006/abio.2000.4533; PMID: 10847613
   PubMed Web of Science ®Google Scholar
• Biaglow JE, Ayene IS, Koch CJ, Donahue J, Stamato TD, Mieyal JJ, et al. Radiation response of cells during altered protein thiol redox. Radiat Res 2003; 159:484 - 94; http://dx.doi.org/10.1667/0033-7587(2003)159[0484:RROCDA]2.0.CO;2; PMID: 12643793
   PubMed Web of Science ®Google Scholar
• Eschiweg F, Bourhis J, Girinski T, Laritigau E, Deble D, Kepa L, et al. Predictive assays of radiation response in patients with head and neck squamous cell carcinoma: A review of the institute gustave roussy experience. IJROBP 1997; 39:845 - 53
   Google Scholar
• Garcea G, Jones DJL, Singh R, Dennison AR, Farmer PB, Sharma RA, et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 2004; 90:1011 - 5; http://dx.doi.org/10.1038/sj.bjc.6601623; PMID: 14997198
   PubMed Web of Science ®Google Scholar
• Gustafson DL, Frederick B, Merz AL, Raben D. Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenografts. Cancer Chemother Pharmacol 2008; 61:179 - 88; http://dx.doi.org/10.1007/s00280-007-0460-5; PMID: 17393165
   PubMed Web of Science ®Google Scholar
• Bianco C, Tortora G, Bianco R, Caputo R, Veneziani BM, Caputo R, et al. Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). Clin Cancer Res 2002; 8:3250 - 8; PMID: 12374696
   PubMed Web of Science ®Google Scholar
• Sugerman PB, Bigby M. Preliminary functional analysis of human epidermal T cells. Arch Dermatol Res 2000; 292:9 - 15; http://dx.doi.org/10.1007/PL00007461; PMID: 10664009
   PubMed Web of Science ®Google Scholar
• Reimers N, Kasper HU, Weissenborn SJ, Stützer H, Preuss SF, Hoffmann TK, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 2007; 120:1731 - 8; http://dx.doi.org/10.1002/ijc.22355; PMID: 17236202
   PubMed Web of Science ®Google Scholar
• Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2009; 74:553 - 61; http://dx.doi.org/10.1016/j.ijrobp.2009.02.015; PMID: 19427557
   PubMed Web of Science ®Google Scholar
• Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal 2005; 7:1630 - 47; http://dx.doi.org/10.1089/ars.2005.7.1630; PMID: 16356126
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci U S A 2001; 98:3404 - 9; http://dx.doi.org/10.1073/pnas.051632198; PMID: 11248091
   PubMed Web of Science ®Google Scholar
• Cai W, Zhang L, Song Y, Wang B, Zhang B, Cui X, et al. Small molecule inhibitors of mammalian thioredoxin reductase. Free Radic Biol Med 2012; 52:257 - 65; http://dx.doi.org/10.1016/j.freeradbiomed.2011.10.447; PMID: 22064364
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Takada Y, Singh S, Myers JN, Aggarwal BB. Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 2004; 111:679 - 92; http://dx.doi.org/10.1002/ijc.20333; PMID: 15252836
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 2008; 52:Suppl 1 S128 - 38; PMID: 18327872
   PubMed Web of Science ®Google Scholar
• Fang J, Lu J, Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 2005; 280:25284 - 90; http://dx.doi.org/10.1074/jbc.M414645200; PMID: 15879598
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4:807 - 18; http://dx.doi.org/10.1021/mp700113r; PMID: 17999464
   PubMed Web of Science ®Google Scholar
• Johnson JJ, Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Lett 2007; 255:170 - 81; http://dx.doi.org/10.1016/j.canlet.2007.03.005; PMID: 17448598
   PubMed Web of Science ®Google Scholar
• Forastiere AA, Trotti A, Pfister DG, Grandis JR. Head and neck cancer: recent advances and new standards of care. J Clin Oncol 2006; 24:2603 - 5; http://dx.doi.org/10.1200/JCO.2006.07.1464; PMID: 16763271
   PubMed Web of Science ®Google Scholar
• Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66:253 - 62; http://dx.doi.org/10.1016/S0167-8140(02)00404-8; PMID: 12742264
   PubMed Web of Science ®Google Scholar
• Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004; 4:277 - 84; http://dx.doi.org/10.1038/nrc1318; PMID: 15057287
   PubMed Web of Science ®Google Scholar
• Okunieff P, Xu J, Hu D, Liu W, Zhang L, Morrow G, et al. Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys 2006; 65:890 - 8; http://dx.doi.org/10.1016/j.ijrobp.2006.03.025; PMID: 16751071
   PubMed Web of Science ®Google Scholar
• Akpolat M, Kanter M, Uzal MC. Protective effects of curcumin against gamma radiation-induced ileal mucosal damage. Arch Toxicol 2009; 83:609 - 17; http://dx.doi.org/10.1007/s00204-008-0352-4; PMID: 18754102
   PubMed Web of Science ®Google Scholar
• Rhee JG, Li D, O’Malley BW Jr., Suntharalingam M. Combination radiation and adenovirus-mediated P16(INK4A) gene therapy in a murine model for head and neck cancer. ORL J Otorhinolaryngol Relat Spec 2003; 65:144 - 54; http://dx.doi.org/10.1159/000072252; PMID: 12925815
   PubMed Web of Science ®Google Scholar
• White JS, Weissfeld JL, Ragin CCR, Rossie KM, Martin CL, Shuster M, et al. The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol 2007; 43:701 - 12; http://dx.doi.org/10.1016/j.oraloncology.2006.09.001; PMID: 17112776
   PubMed Web of Science ®Google Scholar
• Ferris RL, Martinez I, Sirianni N, Wang J, López-Albaitero A, Gollin SM, et al. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer 2005; 41:807 - 15; http://dx.doi.org/10.1016/j.ejca.2004.11.023; PMID: 15763658
   PubMed Web of Science ®Google Scholar
• Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, et al. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol 2002; 22:7405 - 16; http://dx.doi.org/10.1128/MCB.22.21.7405-7416.2002; PMID: 12370288
   PubMed Web of Science ®Google Scholar
• Arnér ES, Nordberg J, Holmgren A. Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem Biophys Res Commun 1996; 225:268 - 74; http://dx.doi.org/10.1006/bbrc.1996.1165; PMID: 8769129
   PubMed Web of Science ®Google Scholar
• Myers JN, Holsinger FC, Jasser SA, Bekele BN, Fidler IJ. An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 2002; 8:293 - 8; PMID: 11801572
   PubMed Web of Science ®Google Scholar